Exelixis (EXEL) Q3 2023 Earnings Call Transcript

EXEL earnings call for the period ending September 30, 2023.

Related Keywords

New York ,United States ,Delaware ,Etzer Darout ,Jay Olson ,Andy Hsieh ,Dana Aftab ,Jing Deng Truist ,Andy Hsieh William Blair ,Joe Catanzaro ,Peter Lawson Barclays ,Jennifer Chan ,Chris Senner ,Gregory Renza ,Michael Schmidt Guggenheim ,Morgan Stanley ,Peter Lamb ,Susan Hubbard ,Stephen Willey ,Mike Morrissey ,Christopher Liu Leerink ,Aakash Tiwari ,Christopher Liu ,Peter Lawson ,Jay Olson Oppenheimer ,Amy Peterson ,America Merrill Lynch ,Silvan Tuerkcan ,Jason Gerberry ,Joe Catanzaro Piper Sandler ,William Blair ,Michael Schmidt ,Piper Sandler ,Jing Deng ,Chris Shibutani ,Yaron Werber ,Alliance For Clinical Trials ,Stephen Willey Stifel Financial Corp ,Public Affairs ,Barclays ,Company Analyst ,Goldman Sachs ,International Kidney Cancer Symposium ,Genentech ,Jason Gerberry Bank ,Vice President ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Exelixis Global Rights ,Metastatic Castration Resistant Prostate Cancer ,Clinical Trials ,Executive Vice President ,Thanks Mike ,Jeff Hung ,Truist Securities ,